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Abstract
Background: Pneumococcal pneumonia is the most common form of community-acquired pneumonia (CAP).
Although a pneumococcal conjugate vaccine has contributed to a reduction in the incidence of pneumococcal
pneumonia among older children and adults, no significant decrease in the incidence has been observed among
persons aged ≥65 years. A low body mass index and hypoalbuminemia are common in Japanese patients with
CAP, but the association of other nutritional parameters with the severity of pneumonia or length of hospital
stay in patients with pneumococcal pneumonia is unclear.
Methods: Fifty-seven previously healthy inpatients who presented with pneumococcal pneumonia were divided into
two groups: those aged ≥65 years (n = 36) and those aged <65 years (n = 21). Patients’ characteristics (the Confusion,
Urea, Respiratory rate, Blood pressure, age >65 years (CURB-65) score), the pneumonia severity index (PSI), and
inflammatory and metabolic nutritional parameters were compared between the two groups.
Results: The older group showed significantly lower serum albumin and cholinesterase (ChE) levels. Multivariate linear
regression analysis revealed that the PSI was positively correlated with age in both groups. In the younger age group,
both the CURB-65 score and PSI showed significant negative correlations with the serum ChE level, and there was a
significant negative correlation between the length of stay and serum total cholesterol (T-cho) level. In the older group,
the fasting period, lymphocyte count, and age showed significant positive correlations with the length of stay. There
was a significant negative correlation between the length of stay and serum albumin level, but no correlation with the
serum ChE or T-cho levels, in the older patients.
Conclusions: Our findings suggest that in patients aged <65 years, age and serum ChE and T-cho levels were
associated with both the severity of pneumococcal pneumonia and length of stay. In contrast, the length of
stay in older patients was associated with multiple factors that differed from those in younger patients. These
differences may reflect age-related immunosenescence in older patients and a greater effect of serum ChE
and T-cho levels on immunity in younger patients.
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Background
Streptococcus pneumoniae (pneumococcus) is the most
common cause of community-acquired pneumonia (CAP)
[1]. The mortality rate of pneumococcal pneumonia is ap-
proximately 12 % and has not dramatically changed in the
past 50 years despite medical advances [2]. A pneumococ-
cal conjugate vaccine has contributed to a reduction in
the incidence of disease among older children and adults
[3–5]; however, no significant decrease in the incidence of
invasive pneumococcal disease has been observed among
persons aged >64 years [5]. Age of ≥65 years is also an
independent predictive factor for in-hospital mortality of
patients with CAP [6], and risk scores for patients with
CAP, such as the Confusion, Urea, Respiratory rate, Blood
pressure, age >65 years (CURB-65) score and pneumonia
severity index (PSI), set a high value for age in patients
with CAP [6, 7]. Moreover, the incidence of CAP tends to
increase with age among people aged ≥65 years [8]. Age
was reported to be significantly associated with in-hospital
death only in patients with CAP aged >85 years with
chronic obstructive disease, and a patient age of 65 to
84 years showed no association with in-hospital death [9].
This suggests that factors other than age itself, but that
depend on age, are associated with CAP severity in pa-
tients ≥65 years old. A recent study reported a higher fre-
quency of a low body mass index (BMI) (<18.0 kg/m2)
and hypoalbuminemia (≤3.5 g/dL) in older Japanese pa-
tients with CAP than in control participants and found
that hypoalbuminemia was associated with a significantly
increased risk of pneumonia [10]. These finding suggest
that malnutrition may be an important risk factor for
CAP. Another study revealed that physical activity, nutri-
tional status, and dehydration were significant prognostic
factors in very old patients with pneumonia [11]. More-
over, in patients with CAP, a low serum albumin level
(≤3.0 g/dL) and a low BMI during hospitalization were as-
sociated with death from pneumonia during a follow-up
period after discharge [12]. However, these studies in-
cluded patients with aspiration pneumonia or pneumonia
resulting from bacteria other than S. pneumonia [8, 12].
The primary objectives of this study were to examine
the differences in metabolic nutritional parameters be-
tween patients aged ≥65 and <65 years with pneumo-
coccal pneumonia and to elucidate the association
between metabolic nutritional parameters and the se-
verity of pneumococcal pneumonia at admission and
during hospitalization.
Methods
Study design and population
In total, 134 consecutive patients (52 male, 82 female)
who were admitted to the Department of Internal Medi-
cine in our hospital for the treatment of pneumococcal
pneumonia from April 2009 to March 2014 were
retrospectively identified in our departmental database.
Diagnosis of pneumococcal pneumonia was confirmed
by (i) detection of S. pneumoniae from a sputum culture,
(ii) detection of S. pneumonia antigen in urine, or (iii)
findings suggestive of bacterial pneumonia on imaging
modalities such as X-ray and computed tomography.
Of these patients, 57 (21 male, 36 female) who had no
remarkable medical history (including pneumococcus
vaccination), were taking no medications, showed good
activities of daily living, and had a full Functional Inde-
pendence Measure (FIM) score were included in this
study. None of the patients enrolled in this study
needed mechanical ventilation support. All patients
could be discharged from our hospital with a full FIM
score and with no sequelae.
The study was conducted in accordance with the
Declaration of Helsinki and approved by the Gunma
Chuo Hospital Ethics Committee. Written informed
consent for inclusion in the study was obtained from all
enrolled patients.
Clinical and laboratory findings
Patients were divided into two groups according to their
age upon admission: those ≥65 years old (n = 36; age
range, 65–90 years) and those <65 years old (n = 21; age
range, 20–64 years). The mean age, sex ratio, BMI,
CURB-65 score, and PSI were compared between these
two groups. The CURB-65 is a scoring system that
predicts mortality in patients with CAP [6]. The PSI is
also a useful clinical tool for medical practitioners to cal-
culate the probability of morbidity and mortality among
patients with CAP [7]. The numbers of patients diag-
nosed with severe pneumonia (CURB-65 score of ≥4
and/or PSI of >130) were compared between the two
groups. Inflammatory parameters (white blood cell count
and serum C-reactive protein level) and metabolic nutri-
tional parameters (lymphocyte count and serum levels of
albumin [Alb], total cholesterol [T-cho], and cholinester-
ase [ChE]) [13, 14] were also compared between the two
groups. Whole blood and plasma samples were obtained
soon after admission.
Antibiotic therapy and nutritional support
The patients were given antibiotic treatment in accord-
ance with the 2005 guidelines for the management of
CAP in adults provided by the Japanese Respiratory So-
ciety [15], the validity of which was proven in 2012 by a
nationwide study in Japan [16]. The guideline committee
recommended intravenous administration of high-dose
penicillin, ceftriaxone, fourth-generation cephalosporins,
carbapenems, or vancomycin for initial treatment of in-
patients with pneumococcal pneumonia. In this study,
the attending physicians chose a intravenous antibiotic,
including high-dose aminobenzylpenicillin (6–8 g/day),
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ceftriaxone (2 g/day), or meropenem (2 g/day), which
are frequently prescribed for primary treatment of CAP
in our hospital. None of the enrolled patients were
treated with oral or intravenous corticosteroids.
On the day of admission, all patients received periph-
eral parenteral nutrition (PPN) with intravenous infusion
of both lactated Ringer’s solution (500 mL/day) and
BFLUID (500 mL/day) (Otsuka Pharmaceutical Co., Ltd.,
Tokushima, Japan). BFLUID is an infusion preparation
with an energy concentration of 4.2 kcal/mL, a pH of
6.7, and an osmotic pressure ratio of 3.0. It includes
sugar (10.7 % w/v), amino acids, electrolytes, and vita-
min B1, but no fat emulsion. From the second day of
admission onward, the dose of intravenous nutrition
infusion was readjusted to a maximum of 1000 mL/day
in patients who were unable to eat enough food. The
addition of BFLUID infusion to the usual lactated
Ringer’s solution was determined by the attending
physician. PPN with BFLUID was terminated when pa-
tients could eat more than half of their meals. Differ-
ences in the length of hospital stay, fasting period,
duration of PPN, caloric intake by oral ingestion or
PPN, types of antibiotics selected, and duration of anti-
biotic administration were compared between the two
age groups. Correlations between length of stay and
independent variables including age, inflammatory pa-
rameters, metabolic nutritional parameters, fasting period,
oral or parenteral caloric intake, PPN duration, CURB-65
score, and PSI were investigated. Multivariate stepwise
linear regression analysis was also performed to determine
the factors associated with length of stay.
Statistical analysis
Continuous data are presented as mean ± standard devi-
ation or n (%). Comparisons of the admission data be-
tween the two age groups were performed using the
unpaired t test for parametric data and the Mann–
Whitney U test for nonparametric data. Nonparamet-
ric data, such as numbers of patients, were compared
between the two groups using the χ2 test. Pearson’s
correlation coefficient was used to analyze correlations be-
tween the CURB-65 score or PSI and independent vari-
ables, including age, BMI, and metabolic nutritional
parameters (lymphocyte count and serum Alb, T-cho,
and ChE levels). Similarly, Pearson’s correlation coeffi-
cient was used to analyze correlations between length
of stay and independent variables including age, nutri-
tional status parameters, fasting period, oral or paren-
teral caloric intake, PPN duration, CURB-65 score, and
PSI. A P-value of <0.05 was considered to indicate a
statistically significant association in the univariate ana-
lysis. Multivariate stepwise regression analysis was then
performed to specify the independent variables showing
a significant association with the CURB-65 score and PSI
on admission as well as the length of stay in both
groups. Basically, independent variables with a P-value
of <0.1 in the univariate analysis were chosen for the
multivariate analysis. Multicollinearity was assessed
using the variance inflation factor. A variance inflation
factor of >10 indicates serious multicollinearity, and a
value of >4 may be a cause for concern. The variables
that were found to be significantly or closely associated
in the univariate analyses were included in the multi-
variate stepwise linear regression analyses, with P < 0.05
considered statistically significant. All analyses were
performed using IBM SPSS Statistics for Windows, ver-
sion 21.0 J (IBM Corp., Armonk, NY, USA). Datasets
used for statistical analysis could not be published be-
cause Gunma Chuo Hospital Ethics Committee pro-
hibits release of individual data to the public.
Results
The characteristics of the patients in the two age groups
are shown in Table 1. There were no significant differ-
ences in the sex ratio or BMI between the two groups.
Interestingly, both groups showed a low BMI. In particu-
lar, the BMI in the ≥65-year-old group was nearly the
lower limit of normal (18.5 kg/m2) [17]. The CURB-65
score was significantly higher in the older group than in
the younger group (1.9 ± 0.9 vs 0.5 ± 0.9, respectively;
P < 0.001), as was the PSI (105.6 ± 24.5 vs 28.2 ± 46.2,
respectively; P < 0.001). The proportion of patients
who presented with severe pneumonia was higher in
the older group (25 % vs 5 %, respectively), but the
difference between the two groups did not reach statistical
significance (P = 0.052). Among the inflammatory and
metabolic nutritional parameters, the older group had sig-
nificantly lower levels of serum Alb (3.27 ± 0.59 vs 3.76 ±
0.64 g/dL, respectively; P = 0.005) and ChE (189.8 ± 54.3
vs 237.0 ± 78.1 U/L, respectively; P = 0.010).
Correlation between CURB-65 score or PSI and
independent variables on admission
The CURB-65 score on admission in the older group
showed no significant correlations among the independ-
ent variables, including age, BMI, and metabolic nutri-
tional parameters (Table 2A). The CURB-65 score in the
younger group was significantly correlated with the age
of the patients. The PSI on admission was significantly
correlated with patient age in both groups (Table 2B).
Multivariate stepwise linear regression analysis was
then carried out to determine the factors associated
with the CURB-65 score and PSI in both groups. In the
older group, a multivariate regression analysis of the
CURB-65 score could not be performed because no in-
dependent variable had a P-value of <0.10 in the uni-
variate analysis. The PSI in the older group showed a
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weak correlation with patient age (correlation coeffi-
cient [r] = 0.467, P = 0.004) (Table 3).
Interestingly, multivariate regression analysis revealed
that both the CURB-65 score and PSI in the younger
group were correlated with the ChE level, although the
absolute value of the standardized regression coefficient
(β) of patient age was larger than that of the serum ChE
level. Specifically, a weak but significant negative correl-
ation was observed between the CURB-65 score and
ChE level (β = −0.409, P = 0.040) and between the PSI
and serum ChE level (β = −0.347, P = 0.046).
Clinical course during hospitalization
All patients enrolled in this study were discharged from
the hospital with a full FIM score, and no patient had
delayed discharge because of social or health issues such
as refusal to leave the hospital or the need for additional
rehabilitation to recover activities of daily living. None
of the patients was readmitted to our hospital within
1 year after discharge. However, the clinical courses dur-
ing hospitalization differed between the two age groups.
Specifically, the hospitalization period was significantly
longer in the older than younger group (17.5 ± 12.9 vs
9.0 ± 3.4 days, respectively; P = 0.001) (Table 4). The
older group also had a significantly longer fasting period
(2.7 ± 7.2 vs 0.2 ± 0.8 days, respectively; P = 0.022), PPN
implementation period (8.4 ± 11.4 vs 2.7 ± 2.6 days, re-
spectively; P = 0.014), and antibiotic administration period
(8.9 ± 2.6 vs 6.7 ± 2.9 days, respectively; P = 0.002). In
addition, caloric intake by oral ingestion was significantly
lower in the older group (1357.9 ± 533.1 vs 1652.4 ±
366.5 kcal/day, respectively; P = 0.03), while the PPN
caloric intake was significantly higher (266.9 ± 49.4 vs
144.8 ± 153.6 kcal/day, respectively; P = 0.034). Regarding
the antibiotics selected for treatment of pneumococcal
pneumonia, the proportion of patients prescribed merope-
nem was significantly higher in the older group.
Correlations between variables and length of stay
Correlation analysis of factors associated with length
of stay revealed interesting results (Table 5). In the
younger group, the serum Alb (r = −0.542, P = 0.011),
T-cho (r = −0.558, P = 0.009), and ChE levels (r = −0.493,
P = 0.023) and the fasting period (r = 0.403, P = 0.023)
were significantly correlated with the length of stay. In the
older group, the serum Alb (r = −0.527, P = 0.001) and
ChE levels (r = −0.516, P = 0.001) and the fasting
period (r = 0.567, P < 0.001) showed significant correla-
tions with the length of stay, but the serum T-cho level
did not show a significant correlation. In addition,
age (r = 0.479, P = 0.003), BMI (r = −0.488, P = 0.003),
oral caloric intake (r = −0.445, P = 0.007), and PPN
duration (r = 0.832, P < 0.001) showed significant cor-
relations with the length of stay only in the older
Table 1 Comparison of patient characteristics and inflammatory








Mean age (years) 80.1 ± 7.7 44.5 ± 13.9 <0.001*
Sex (male/female) 13/23 12/9 0.123
Body mass index (kg/m2) 18.7 ± 4.1 19.6 ± 2.1 0.284
CURB-65 score on admission 1.9 ± 0.9 0.5 ± 0.9 <0.001*
PSI on admission 105.6 ± 24.5 28.2 ± 46.2 <0.001*
Inflammatory parameters
White blood cell count (/mm3) 12,750 ± 6490 13,300 ± 5460 0.744
C-reactive protein (mg/dL) 12.57 ± 11.97 9.60 ± 9.56 0.297
Nutritional parameters
Lymphocyte count (/mm3) 1415.6 ± 1211.5 1664.0 ± 531.0 0.378
Serum albumin (g/dL) 3.27 ± 0.59 3.76 ± 0.64 0.005*
Total cholesterol (mg/dL) 167.5 ± 49.7 170.3 ± 43.5 0.833
Serum cholinesterase (IU/L) 189.8 ± 54.3 237.0 ± 78.1 0.010*
CURB-65 confusion, urea, respiratory rate, blood pressure, age >65 years, PSI
pneumonia severity index
*Statistically significant (P < 0.05)
Table 2 Correlation between CURB-65 score/PSI and
independent variables including age, body mass index,
and nutritional parameters
A. Univariate analysis of correlations between CURB-65 score and
independent variables
Independent variables ≥65 years (n = 36) <65 years (n = 21)
Age 0.235 (0.167) 0.463 (0.034*)
Body mass index −0.025 (0.883) −0.210 (0.361)
Lymphocyte count −0.164 (0.338) −0.197 (0.392)
Serum albumin −0.249 (0.142) 0.015 (0.948)
Total cholesterol −0.248 (0.146) −0.270 (0.237)
Serum cholinesterase −0.122 (0.477) −0.424 (0.056)
B. Univariate analysis of correlations between PSI and independent
variables
Independent variables ≥65 years (n = 36) <65 years (n = 21)
Age 0.467 (0.004*) 0.640 (0.002*)
Body mass index −0.084 (0.627) −0.012 (0.958)
Lymphocyte count −0.263 (0.122) −0.145 (0.531)
Serum albumin −0.156 (0.365) −0.076 (0.744)
Total cholesterol −0.287 (0.089) −0.016 (0.946)
Serum cholinesterase −0.148 (0.388) −0.367 (0.102)
*P < 0.05. Data are presented as correlation coefficient (P-value)
Akuzawa and Naito BMC Pulmonary Medicine  (2015) 15:149 Page 4 of 8
group. Regarding parameters associated with pneumo-
nia severity, only the CURB-65 score in the younger
group showed a significant correlation with length of
stay (r = 0.438, P = 0.047).
Multivariate linear regression analysis in the older pa-
tients revealed that the fasting period (β = 0.399, P = 0.005),
lymphocyte count (β = 0.315, P = 0.012), and age (β =
0.267, P = 0.044) had a significant positive correlation with
the length of stay and that only the serum Alb level had a
significant negative correlation (β = −0.292, P = 0.024)
(Table 6). In younger patients, however, the serum T-cho
level (β = −0.558, P = 0.009) was the only significant
independent variable and showed a negative correlation
with the length of stay.
Discussion
This study focused on the correlation between nutri-
tional status and disease severity and between nutri-
tional status and length of hospital stay in patients with
pneumococcal pneumonia. Interestingly, the mean BMI
of both age groups nearly reached the lower limit of
normal (18.5 kg/m2). Past studies have shown that a
lower BMI is associated with increased mortality among
patients with CAP [18, 19] and that a higher BMI is
Table 4 Comparison of clinical course, caloric intake, and selected antibiotics during hospitalization
≥65 years (n = 36) <65 years (n = 21) P-value
Clinical course during hospitalization
Length of stay (days) 17.5 ± 12.9 9.0 ± 3.4 0.001*
Fasting period (days) 2.7 ± 7.2 0.2 ± 0.8 0.022*
Duration of PPN implementation (days) 8.4 ± 11.4 2.7 ± 2.6 0.014*
Duration of antibiotic administration (days) 8.9 ± 2.6 6.7 ± 2.9 0.002*
Mean caloric intake
Oral ingestion (kcal/day) 1357.9 ± 533.1 1652.4 ± 366.5 0.030*
PPN (kcal/day) 266.9 ± 49.4 144.8 ± 153.6 0.034*
Selected antibiotics
High-dose ABPC 18 13 0.384
Ceftriaxone 6 6 0.288
Meropenem 12 2 0.044*
PPN peripheral parenteral nutrition, ABPC aminobenzylpenicillin
*P < 0.05
Table 3 Correlation between CURB-65 score/PSI and independent variables including age, body mass index, and nutritional
parameters
Multivariate linear regression analysis
1. Factors associated with PSI in the ≥65-year-old group (r = 0.467; r2 = 0.219; adjusted r2 = 0.196)
Independent variable B (95 % CI) β t VIF P
Age 1.477 (0.504–2.450) 0.467 3.084 1.000 0.004*
2. Factors associated with CURB-65 score in the <65-year-old group (r = 0.618; r2 = 0.382; adjusted r2 = 0.313)
Independent variables B (95 % CI) β t VIF P
Age 0.030 (0.004–0.056) 0.450 2.429 1.001 0.026*
Serum cholinesterase −0.005 (−0.009 to −0.000) −0.409 −2.208 1.001 0.040*
3. Factors associated with PSI in the <65-year-old group (r = 0.728; r2 = 0.529; adjusted r2 = 0.477)
Independent variables B (95 % CI) β t VIF P
Age 2.096 (0.962–3.229) 0.629 3.886 1.001 0.001*
Serum cholinesterase −0.205 (−0.406 to −0.004) −0.347 −2.142 1.001 0.046*
(r = 0.467; r2 = 0.219; 2 adjusted r2 = 0.196)
r multiple correlation coefficient, r2 coefficient of determination, B nonstandardized regression coefficient, CI confidence interval; β standardized regression
coefficient; VIF variance inflation factor.
*P < 0.05
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associated with reduced mortality at 30 days after admis-
sion in patients with pneumococcal or Haemophilus CAP
[20]. In the present study, however, BMI showed no
significant correlations with pneumonia severity on ad-
mission or length of stay in the multivariate regression
analysis in either age group. The most probable reason for
this is selection bias resulting from the small number of
enrolled patients in this study. Most of the patients had a
low BMI, leading to the inability to show a significant as-
sociation between BMI and pneumonia severity or length
of stay.
It is understandable that both the CURB-65 score and
PSI on admission were higher in the older than younger
group because patient age is a determinant of both
scores [6, 7]. The CURB-65 score is commonly used to
discriminate severely ill patients, while the PSI has been
well validated for the assessment of patients with a low
mortality risk [21]. Interestingly, multivariate regression
analysis showed significantly negative correlations be-
tween the serum ChE level and the pneumonia severity
score, including both the CURB-65 score and PSI, only
in the younger group. To the best of our knowledge, an
association between the serum ChE level and severity of
CAP has not been reported previously. These findings
suggest that the serum ChE level may indirectly affect
the immune response of patients with CAP. Acetylcho-
line was recently reported to have immunosuppressive
effects on macrophages or other immune cells containing
the α7 nicotinic acetylcholine receptor by suppressing in-
flammatory cytokine production [22]. This regulatory
pathway mainly involves a link between neurotransmitters
in blood and macrophages [22]. Therefore, low serum
ChE levels, including both acetylcholinesterase and butyr-
ylcholinesterase, may enhance immunosuppression by
accumulation of unhydrolyzed acetylcholine, leading to
activation of the cholinergic anti-inflammatory pathway
and resultant aggravation of pneumococcal pneumonia
[22, 23]. Actually, the use of ChE inhibitors in hospitalized
patients with dementia has been suggested to increase the
risk of respiratory disease, including pneumonia [24].
However, it should again be noted that there was a sig-
nificant correlation between patient age and the CURB-
65 score/PSI in both age groups in the present study.
Advancing age is closely related to weakened integrity
of physical barriers as well as low immune responsive-
ness against invading pathogens because of respiratory
tract immunosenescence [25]. In the multivariate ana-
lysis, the absence of a significant correlation between
independent variables and the PSI (other than age) in
the older group may suggest more pronounced effects
of immunosenescence on pneumonia severity in older
patients with CAP.
Table 5 Correlations between length of stay and independent
variables in univariate analysis
Independent variables ≥65 years (n = 36) <65 years (n = 21)
Age 0.479 (0.003*) −0.062 (0.788)
Body mass index −0.488 (0.003*) −0.145 (0.532)
Nutritional parameters
Lymphocyte count 0.305 (0.071) −0.163 (0.480)
Serum albumin −0.527 (0.001*) −0.542 (0.011*)
Total cholesterol 0.244 (0.152) −0.558 (0.009*)
Serum cholinesterase −0.516 (0.001*) −0.493 (0.023*)
Parameters related to nutrition
support
Fasting period 0.567 (<0.001*) 0.403 (0.070)
Oral caloric intake −0.445 (0.007*) 0.077 (0.740)
PPN caloric intake 0.163 (0.342) 0.237 (0.301)
PPN duration 0.832 (<0.001*) 0.115 (0.620)
Parameters associated with
pneumonia severity
CURB-65 score 0.295 (0.146) 0.438 (0.047*)
PSI 0.146 (0.396) 0.282 (0.215)
*P < 0.05. Data are presented as correlation coefficient (P-value)
Table 6 Multivariate stepwise linear regression analysis of factors associated with length of stay
1. Factors associated with length of stay in the ≥65-year-old group (r = 0.778; r2 = 0.605; adjusted r2 = 0.554)
Independent variables B (95 % CI) β t VIF P
Fasting period 0.718 (0.239–1.198) 0.399 3.055 1.340 0.005*
Lymphocyte count 0.003 (0.001–0.006) 0.315 2.680 1.086 0.012*
Serum albumin −6.345 (−11.778 to −0.913) −0.292 −2.382 1.176 0.024*
Age 0.446 (0.012–0.880) 0.267 2.098 1.086 0.044*
2. Factors associated with hospitalization period in the <65-year-old group (r = 0.558; r2 = 0.311; adjusted r2 = 0.275)
Independent variable B (95 % CI) β t VIF P
Serum total cholesterol −0.043 (−0.074 to −0.012) −0.558 3.055 1.000 0.009*
*P < 0.05
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Regarding length of stay, only the serum T-cho level
showed a significant negative correlation in the youn-
ger group in the multivariate regression analysis. Past
studies have shown that a lower serum T-cho level is
associated with a risk of CAP in young patients [26]
and that a low serum high-density lipoprotein choles-
terol level may be a poor prognostic factor in patients
with severe CAP [27]. Recent studies have revealed
that alveolar epithelial type II cells and alveolar mac-
rophages receive cholesterol from circulating high-density
and low-density lipoprotein [28]. Alveolar epithelial type
II cells also play a pivotal role in alveolar injury repair and
homeostatic maintenance [29]. Accordingly, a lower
T-cho level may be associated with dysfunction of al-
veolar epithelial type II cells and alveolar macrophages,
slowing the recovery of pneumococcal pneumonia. On
the other hand, in the older group, the age, fasting period,
and lymphocyte count showed a significant positive cor-
relation with the length of stay, while the serum Alb level
was the only independent variable showing a significant
negative correlation in the multivariate regression analysis.
These results revealed different independent factors asso-
ciated with length of stay in the two age groups, suggest-
ing that multiple factors related to immunosenescence
may affect length of stay in the elderly [25]. Actually, older
patients with CAP showed a lower systemic inflammatory
response than did younger patients with CAP despite
equivalent serum concentrations of proinflammatory cyto-
kines [30]. The number and functions of T lymphocytes
also decrease with age, and hypoalbuminemic malnutri-
tion can depress the activities of T lymphocytes [31, 32].
Moreover, fasting can decrease the activities of both mu-
cosal T and B cells in terms of their ability to maintain
pulmonary lymphocyte populations and mucosal IgA
secretion in the respiratory tract and intestinal mucosa
[33, 34]; thus, immune dysfunction resulting from immu-
nosenescence, hypoalbuminemia, or fasting may be associ-
ated with a prolonged length of stay in older patients.
However, the reason why the lymphocyte count was posi-
tively correlated with the length of stay only in the older
group in the present study despite the fact that there
were no significant differences in the lymphocyte
count between the older and younger groups remains
unclear. Therefore, further research is required to clarify
the functional alterations of lymphocytes in older patients
with pneumococcal pneumonia.
Limitations
This study is limited by the relatively small number of
patients from a single institution, possible selection bias,
and the retrospective cross-sectional design. We mainly
used univariate and multivariate linear regression ana-
lyses to investigate the association between independent
variables and the severity of pneumonia or length of
stay. Therefore, the relationship between these variables
is unclear. Similarly, the clinical effects of antibiotics on
length of stay are unclear. In addition, the associations
of serum low-density lipoprotein, high-density lipopro-
tein, lymphocyte subsets, and objective nutritional pa-
rameters with body composition such as lean body mass
were not measured. Prospective cohort studies are
needed to further explore these interactions.
Conclusions
The severity of pneumococcal pneumonia was most
strongly correlated with patient age in both the ≥65-
and <65-year-old groups. Notably, in the younger
group, the serum ChE level was negatively correlated
with the severity of pneumonia and the serum T-cho
level was the only independent variable that was
negatively correlated with the length of stay. In the
older group, the fasting period, lymphocyte count,
and age were positively correlated with the length of
stay, while the serum Alb level was negatively corre-
lated. These differences may reflect age-related immu-
nosenescence in older patients and the marked effects
of the serum ChE and T-cho levels on immunity in
younger patients.
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